Literature DB >> 27485920

Analysis of adaptive mutations selected during the consecutive passages of hepatitis E virus produced from an infectious cDNA clone.

Shigeo Nagashima1, Tominari Kobayashi1, Toshinori Tanaka1, Suljid Jirintai1, Masaharu Takahashi1, Tsutomu Nishizawa1, Hiroaki Okamoto2.   

Abstract

To characterize the genomic mutations of hepatitis E virus (HEV) during consecutive passages associated with adaptation to growth in cell culture, a cloned genotype 3 HEV [pJE03-1760F/wt, starting virus (SV)] was passaged 10 times in A549 cells, and the entire genomic sequence of the passage 10 (P10) progeny was determined. Compared to SV, P10 virus possessed two non-synonymous (T2808C and A5054G) and four synonymous mutations (C1213T, T2557C, C3118T and C4435T) in the ORF1. Full-length infectious cDNA clones with a single, double (T2808C and A5054G), or all six mutations, identical to P10, were constructed, and their replication capacity was compared. Four (C1213T, T2557C, T2808C and A5054G) of the six viruses with a single mutation grew more efficiently than SV. The P10 virus propagated more rapidly and grew more efficiently than SV and T2808C+A5054G and reached a higher viral load (95.1- and 8.5-fold, respectively) at 20days post-inoculation. An immunofluorescence analysis revealed that a high percentage (>80%) of cells inoculated with the P10 virus expressed ORF2 proteins, while relatively low percentages (nearly 30% or 5%) inoculated with T2808C+A5054G or SV, respectively, expressed ORF2 proteins. We found that not only non-synonymous but also synonymous HEV mutations are independently associated with increased virus production.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptation; Cell culture; Hepatitis E virus; Infectious cDNA clone; Reverse genetics system; Synonymous mutation

Mesh:

Substances:

Year:  2016        PMID: 27485920     DOI: 10.1016/j.virusres.2016.07.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Takashi Nishiyama; Masaharu Takahashi; Kazumoto Murata; Hiroaki Okamoto
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

Review 2.  Genetic Variability and Evolution of Hepatitis E Virus.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Hiroaki Okamoto
Journal:  Viruses       Date:  2019-05-18       Impact factor: 5.048

3.  The Capsid (ORF2) Protein of Hepatitis E Virus in Feces Is C-Terminally Truncated.

Authors:  Takashi Nishiyama; Koji Umezawa; Kentaro Yamada; Masaharu Takahashi; Satoshi Kunita; Isao Kii; Hiroaki Okamoto
Journal:  Pathogens       Date:  2021-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.